Data / Form D filings / IMMUCELL CORP /DE/
IMMUCELL CORP /DE/: Form D filing
IMMUCELL CORP /DE/, a pharmaceuticals company in Portland, ME, filed a Form D with the SEC in 2016. The latest, on October 24, 2016, reports $3.5 million sold of an offering with no set size to 19 investors.
Find out what IMMUCELL CORP /DE/ does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 56 EVERGREEN DRIVE, Portland, ME, 04103
- Phone
- (207) 878-2770
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 811641
The full lists. Form D filings in Maine: 101 rows, $5.05, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 24, 2016 | New notice | Indefinite | $3,464,370 | Indefinite | 19 | Oct 21, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PAUL F WAINMAN | Director | |
| JOSEPH F CRABB | Executive Officer, Director | |
| DAVID F CUNNINGHAM | Director | |
| ELIZABETH F WILLIAMS | Executive Officer | |
| DAVID F TOMSCHE | Director | |
| LINDA F RHODES | Director | |
| JONATHAN F ROTHSCHILD | Director | |
| BOBBI F BROCKMANN | Executive Officer | |
| MICHAEL F BRIGHAM | Executive Officer, Director |
Every Form D from the week of Oct 24, 2016 · All recent filings in Maine · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what IMMUCELL CORP /DE/ reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.